Tafamidis delays neurological progression comparably across Val30Met and non‐Val30Met genotypes in transthyretin familial amyloid polyneuropathy

BACKGROUND AND PURPOSE: To better characterize the effects of tafamidis in non‐Val30Met patients with transthyretin familial amyloid polyneuropathy, this post hoc analysis compared the neurological results from a 12‐month, open‐label study of non‐Val30Met versus Val30Met patients at month 12 from th...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Eur J Neurol
Main Authors: Gundapaneni, B. K., Sultan, M. B., Keohane, D. J., Schwartz, J. H.
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2017
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5838526/
https://ncbi.nlm.nih.gov/pubmed/29115008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ene.13510
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares